Sort
27,075 grants matching “cholesterol”
ABCG1 Function in Diabetes
$496,651Catherine C Hedrick · University Of Virginia · R01 · FY2008 · HL
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma
$496,614Janey L Wiggs · Massachusetts Eye And Ear Infirmary · R01 · FY2024 · EY
MCI, Insulin and Cholesterol in a Community Sample
$496,594Suzanne Craft · Seattle Inst For Biomedical/Clinical Res · R01 · FY2007 · AG
Post-lysosomal cholesterol trafficking networks
$496,592Jean E Schaffer · Washington University · R01 · FY2019 · HL
Genetics and Personalized Medicine: From Population Studies to Clinical Therapy
$496,501Christie M Ballantyne · Baylor College Of Medicine · P30 · FY2009 · HL
Clinical Investigations of Niemann-Pick Disease, type C
$496,470Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
Fetal Determinants of Atherosclerosis
$496,453University Of California San Diego · R01 · FY2005 · HL
Prenatal exposure to polyfluoroalkyl chemicals (PFCs)and child growth and development
$496,440Sharon K. Sagiv · University Of California Berkeley · R01 · FY2015 · ES
Therapeutics for the chorioretina
$496,438Sofia P Becerra · National Eye Institute · ZIA · FY2021 · EY
Project 3: Lipolysis regulation and diabetes-impaired regression
$496,387Ira Jay Goldberg · University Of Washington · P01 · FY2023 · HL
GENETICS OF ARTERIAL AND PROGENITOR ENDOTHELIAL CELLS
$496,374John L Vandeberg · Texas Biomedical Research Institute · P01 · FY2011 · HL
LIPOPROTEIN AND HYPERTENSION QTL CANDIDATE GENES
$496,362Laura A Cox · Texas Biomedical Research Institute · P01 · FY2011 · HL
Diet and Gene Effects on Atherosclerosis and CVD Risk
$496,362Michael C. Mahaney · Texas Biomedical Research Institute · P01 · FY2011 · HL
MicroRNAs as Biomarkers for Obstructive Sleep Apnea
$496,283Ulysses J Magalang · University Of Pennsylvania · P01 · FY2023 · HL
Intracellular Transport: The Mannose Phosphate Receptor
$496,255Suzanne R Pfeffer · Stanford University · R01 · FY2009 · DK
Mechanisms of RPE dysfunction in macular degenerations: role of intracellular complement activation
$495,911Aparna Lakkaraju · University Of California, San Francisco · R01 · FY2022 · EY
Core C: Cardiovascular Pathology Core
$495,852Timothy E O'Toole · American Heart Association · P50 · FY2014 · HL
Core C: Cardiovascular Pathology Core
$495,852Timothy E O'Toole · American Heart Association · P50 · FY2015 · HL
Cell Cycle Control of Restenosis by apoE
$495,803Richard Assoian · University Of Pennsylvania · P01 · FY2010 · HL
Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II Study
$495,766Bruce Ovbiagele · Northern California Institute/Res/Edu · R01 · FY2024 · NS
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS
$495,722Robert A Schnoll · University Of Pennsylvania · R01 · FY2014 · DA
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS
$495,722Robert A Schnoll · University Of Pennsylvania · R01 · FY2012 · DA
Lipid and Protein Effects on Monolayer Stability
$495,664Joseph Anthony Zasadzinski · University Of Minnesota · R01 · FY2022 · HL
Multifactor Risk Reduction for Optimal Management in Peripheral Arterial Disease
$495,659Roberta K Oka · University Of California, San Francisco · R01 · FY2007 · NR
The molecular basis for the role of apolipoprotein A-II in cholesterol and triglyceride metabolism
$495,528W. Sean Davidson · University Of Cincinnati · R01 · FY2021 · HL